From reviews of the previous edition:
‘Provides a wealth of information … graphically illustrates the need for practitioners to be thoroughly knowledgeable.’ Toni Belfield, Director of Information, Family Planning Association.
The world’s population is increasing dramatically. At levels over 7 billion, rising annually by over 83 million (with births outstripping deaths by a factor of c. 2.4) the toll this imbalance takes on the environment, developing economies and resources (healthcare, education, rates of poverty) and the lives of women in the poorer parts of the world is increasingly unsustainable. Even in the developed world there is still an unacceptably high rate of unplanned pregnancies, demonstrating that appropriate education at both local and global levels about the full range of available contraception is essential. Using a highly accessible question-and-answer format, John Guillebaud and Anne MacGregor seek to ensure everything needed for good family planning practice is here in this book. Now in its seventh edition and online via ExpertConsult, Contraception: Your Questions Answered remains the market-leading, one-stop resource for family planning professionals worldwide.
1. Chapter 1. Introduction - p. 1 2. Chapter 2. Aspects of Human Fertility and Fertility Awareness: Natural Birth Control - p. 14 3. Chapter 3. Male Methods of Contraception - p. 28 4. Chapter 4. Vaginal Methods of Contraception - p. 38 5. Chapter 5. The Combined Oral Contraceptive – Selection and Eligibility - p. 61 6. Background: Efficacy and Mechanisms - p. 66 7. Effectiveness of the Coc – Circumstances in Which it Can be Reduced - p. 70 8. Drug Interactions Affecting the COC - p. 83 9. Starting Routines with the COC - p. 90 10. Major Systemic Efects of the COC - p. 92 11. Advantages and Beneficial Effects - p. 93 12. Reversibility of the COC - p. 95 13. Main Disadvantages and Problems - p. 99 14. The COC and Neoplasia (Benign and Malignant) - p. 99 15. The COC and Breast Cancer - p. 102 16. The COC and Circulatory Diseases - p. 108 17. The 1995 Controversy About Venous Thromboembolism (VTE) – where are we Now? - p. 119 18. Selection of Users and Formulations: Choosing the ‘Safer Women’ and the ‘Safer Pills’ - p. 124 19. More about THE Available Pill Formulations - p. 130 20. Indications and Contraindications for the COC Method, IN More Depth - p. 134 21. Migraine with and without Aura - p. 144 22. Individual Variation in Blood Levels of Sex Steroids: The Implications for Treatment of the Symptom of Breakthrough Bleeding (BTB) - p. 147 23. Initial Choice of Preparation, and Early Follow-Up - p. 150 24. The Pros and Cons of Phasic Pills - p. 152 25. Chapter 6. The Combined Oral Contraceptive – Follow-UP Arrangements and New Routes of Administration - p. 155 26. Chapter 7. The Progestogen-Only Pill - p. 187 27. Chapter 8. Injectables and Implants - p. 212 28. Chapter 9. Intrauterine Devices and Systems - p. 242 29. Background and Mechanisms - p. 246 30. Effectiveness - p. 250 31. Advantages and Benefits - p. 252 32. Main Problems and Disadvantages - p. 252 33. Intrauterine Pregnancy (IUC IN SITU) - p. 255 34. Extrauterine Pregnancy - p. 256 35. ‘Lost Threads’ - p. 258 36. Expulsion - p. 261 37. Perforation - p. 262 38. Pelvic Infection - p. 263 39. Pain and Bleeding - p. 270 40. Selection of Users and of Devices - p. 273 41. Choice of Device - p. 276 42. Insertion Timing and Procedure - p. 278 43. Patient Information and Follow-Up Arrangements - p. 285 44. Duration of Use – and Reversibility - p. 289 45. GyneFix VIZ - p. 291 46. The Levonorgestrel-Releasing Intrauterine Systems (LNG-IUSs) - p. 293 47. The Future - p. 299 48. Conclusions - p. 300 49. Chapter 10. Emergency (Postcoital) Contraception - p. 305 50. Chapter 11. Contraception for the Young, the Not Quite so Young – and in Future - p. 329 51. Further Reading - p. 358 52. Websites - p. 359 53. Appendix A. Use of Licensed Products in an Unlicensed Way - p. 361 54. Appendix B. ‘Quick Starting’ and ‘Bridging’ - p. 363 55. Appendix C. UKMEC Summary Sheets: Common Reversible Methods - p. 367 56. Index - p. 383
From reviews of the previous edition:
‘Provides a wealth of information … graphically illustrates the need for practitioners to be thoroughly knowledgeable.’ Toni Belfield, Director of Information, Family Planning Association.
The world’s population is increasing dramatically. At levels over 7 billion, rising annually by over 83 million (with births outstripping deaths by a factor of c. 2.4) the toll this imbalance takes on the environment, developing economies and resources (healthcare, education, rates of poverty) and the lives of women in the poorer parts of the world is increasingly unsustainable. Even in the developed world there is still an unacceptably high rate of unplanned pregnancies, demonstrating that appropriate education at both local and global levels about the full range of available contraception is essential. Using a highly accessible question-and-answer format, John Guillebaud and Anne MacGregor seek to ensure everything needed for good family planning practice is here in this book. Now in its seventh edition and online via ExpertConsult, Contraception: Your Questions Answered remains the market-leading, one-stop resource for family planning professionals worldwide.
1. Chapter 1. Introduction - p. 1 2. Chapter 2. Aspects of Human Fertility and Fertility Awareness: Natural Birth Control - p. 14 3. Chapter 3. Male Methods of Contraception - p. 28 4. Chapter 4. Vaginal Methods of Contraception - p. 38 5. Chapter 5. The Combined Oral Contraceptive – Selection and Eligibility - p. 61 6. Background: Efficacy and Mechanisms - p. 66 7. Effectiveness of the Coc – Circumstances in Which it Can be Reduced - p. 70 8. Drug Interactions Affecting the COC - p. 83 9. Starting Routines with the COC - p. 90 10. Major Systemic Efects of the COC - p. 92 11. Advantages and Beneficial Effects - p. 93 12. Reversibility of the COC - p. 95 13. Main Disadvantages and Problems - p. 99 14. The COC and Neoplasia (Benign and Malignant) - p. 99 15. The COC and Breast Cancer - p. 102 16. The COC and Circulatory Diseases - p. 108 17. The 1995 Controversy About Venous Thromboembolism (VTE) – where are we Now? - p. 119 18. Selection of Users and Formulations: Choosing the ‘Safer Women’ and the ‘Safer Pills’ - p. 124 19. More about THE Available Pill Formulations - p. 130 20. Indications and Contraindications for the COC Method, IN More Depth - p. 134 21. Migraine with and without Aura - p. 144 22. Individual Variation in Blood Levels of Sex Steroids: The Implications for Treatment of the Symptom of Breakthrough Bleeding (BTB) - p. 147 23. Initial Choice of Preparation, and Early Follow-Up - p. 150 24. The Pros and Cons of Phasic Pills - p. 152 25. Chapter 6. The Combined Oral Contraceptive – Follow-UP Arrangements and New Routes of Administration - p. 155 26. Chapter 7. The Progestogen-Only Pill - p. 187 27. Chapter 8. Injectables and Implants - p. 212 28. Chapter 9. Intrauterine Devices and Systems - p. 242 29. Background and Mechanisms - p. 246 30. Effectiveness - p. 250 31. Advantages and Benefits - p. 252 32. Main Problems and Disadvantages - p. 252 33. Intrauterine Pregnancy (IUC IN SITU) - p. 255 34. Extrauterine Pregnancy - p. 256 35. ‘Lost Threads’ - p. 258 36. Expulsion - p. 261 37. Perforation - p. 262 38. Pelvic Infection - p. 263 39. Pain and Bleeding - p. 270 40. Selection of Users and of Devices - p. 273 41. Choice of Device - p. 276 42. Insertion Timing and Procedure - p. 278 43. Patient Information and Follow-Up Arrangements - p. 285 44. Duration of Use – and Reversibility - p. 289 45. GyneFix VIZ - p. 291 46. The Levonorgestrel-Releasing Intrauterine Systems (LNG-IUSs) - p. 293 47. The Future - p. 299 48. Conclusions - p. 300 49. Chapter 10. Emergency (Postcoital) Contraception - p. 305 50. Chapter 11. Contraception for the Young, the Not Quite so Young – and in Future - p. 329 51. Further Reading - p. 358 52. Websites - p. 359 53. Appendix A. Use of Licensed Products in an Unlicensed Way - p. 361 54. Appendix B. ‘Quick Starting’ and ‘Bridging’ - p. 363 55. Appendix C. UKMEC Summary Sheets: Common Reversible Methods - p. 367 56. Index - p. 383
